Greenway Greenhouse Cannabis Corp. (GWAY) AI Stock Analysis

• Market Cap: C$32.99M
• Dividend Yield: N/A
• Average Volume (3M): 3.09K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.96
• Revenue Growth: 44.21%
• EPS Growth: 21.93%
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 37
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): N/A
• Shares Outstanding: 131,974,600
• 10 Day Avg. Volume: 2,100
• 30 Day Avg. Volume: 3,093
• PEG Ratio: -0.42
• Price to Book (P/B): 3.10
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -41.28
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 44 Neutral
• Price Target: ―

The overall score reflects significant revenue growth and strategic corporate actions but is weighed down by financial strain and technical bearish trends. The financial performance remains a key concern with high leverage and cash flow issues, while technical indicators suggest caution. Positive corporate events offer potential upside if financial weaknesses are addressed.

Greenway Greenhouse Cannabis Corp. Business Overview & Revenue Model

Company Description

Greenway Greenhouse Cannabis Corp. (GWAY) is a company operating in the agricultural and cannabis sectors. It specializes in the cultivation, production, and distribution of high-quality cannabis products, leveraging advanced greenhouse technology to optimize growth conditions and ensure sustainable practices. The company is committed to providing premium cannabis to both medical and recreational markets, with a focus on innovation, quality, and environmental responsibility.

How the Company Makes Money

Greenway Greenhouse Cannabis Corp. generates revenue primarily through the sale of its cannabis products to various markets, including medical dispensaries and recreational retailers. The company utilizes its state-of-the-art greenhouse facilities to produce cannabis efficiently and sustainably, reducing costs and enhancing product quality. Revenue streams include the sale of dried cannabis flowers, oils, and other derivative products. Key partnerships with distributors and retailers help expand the company's reach and market presence, contributing significantly to its earnings. Additionally, Greenway may engage in strategic collaborations or white-label agreements to further diversify its revenue sources.

Greenway Greenhouse Cannabis Corp. Financial Statement Overview

Summary

Greenway Greenhouse Cannabis Corp. shows significant revenue growth but faces challenges with profitability and cash flow. High leverage and negative earnings margins highlight financial strain, while cash flow issues threaten operational sustainability. Addressing these areas is crucial for financial health improvement.

Income Statement

The company shows a negative gross profit margin and net profit margin in the TTM, indicating difficulty in covering costs. Revenue has grown significantly from the previous year, suggesting potential market expansion. However, the negative EBIT and EBITDA margins reflect operational inefficiencies.

Balance Sheet

The debt-to-equity ratio is high, indicating significant leverage, and the equity ratio shows low equity relative to total assets. ROE is negative due to net losses, highlighting profitability challenges. The balance sheet reflects a risk of financial instability.

Cash Flow

Free cash flow is negative, and both operating and free cash flow to net income ratios are unfavorable, indicating cash flow issues. The growth rate of free cash flow is not positive, suggesting the company struggles to generate cash from operations.

Breakdown	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement
Total Revenue	5.23M	5.62M	1.98M	0.00	0.00
Gross Profit	-335.38K	741.99K	844.02K	487.88K	-465.31K
EBITDA	-2.21M	-632.92K	-1.36M	-727.12K	-1.57M
Net Income	-4.72M	-2.61M	-2.92M	-1.23M	-2.18M
Balance Sheet
Total Assets	33.09M	35.30M	35.63M	25.11M	17.61M
Cash, Cash Equivalents and Short-Term Investments	1.53M	3.64M	7.48M	3.46M	1.44M
Total Debt	16.02M	13.96M	16.67M	13.85M	8.00M
Total Liabilities	21.17M	20.36M	18.77M	14.85M	8.74M
Stockholders Equity	11.92M	14.95M	16.86M	10.26M	8.87M
Cash Flow
Free Cash Flow	-4.96M	-4.38M	-4.10M	-5.95M	-5.53M
Operating Cash Flow	-2.05M	2.23M	-1.97M	-592.08K	-441.11K
Investing Cash Flow	-2.92M	428.31K	-2.12M	-5.36M	-5.09M
Financing Cash Flow	2.85M	-6.49M	8.12M	7.97M	5.82M

Greenway Greenhouse Cannabis Corp. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.26
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:GWAY, the sentiment is Positive. The current price of 0.26 is above the 20-day moving average (MA) of 0.24, above the 50-day MA of 0.21, and below the 200-day MA of 0.29, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 66.52 is Neutral, neither overbought nor oversold. The STOCH value of 83.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:GWAY.

Greenway Greenhouse Cannabis Corp. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
OGI	71 Outperform	$278.48M	19.88	4.76%	―	26.93%	―
CRON	65 Neutral	$1.09B	15.63	4.61%	―	38.16%	―
ACB	51 Neutral	$368.41M	113.72	3.05%	―	26.98%	―
Sector *	46 Neutral	C$201.68M	-3.23	-23.14%	1.87%	20.75%	-0.36%
GWAY	44 Neutral	C$32.99M	―	-18.73%	―	44.21%	21.93%
WEED	43 Neutral	$315.66M	―	-122.10%	―	-18.39%	35.21%

Greenway Greenhouse Cannabis Corp. Corporate Events

Greenway Greenhouse Cannabis Reports Strong Q3 Growth Amid Rising Cannabis Prices

Greenway Greenhouse Cannabis Corporation reported a 21% increase in net revenue for the third quarter of 2025, compared to the same period in 2024, reaching $1,676,721. The company also saw a 57% increase in net revenue for the nine months ending December 31, 2024, surpassing the previous full fiscal year. The company attributes its growth to rising cannabis prices and the successful launch of new products and brands in the Canadian recreational market. Greenway’s MillRite brand maintained its strong market position, and the company is looking to expand its distribution both domestically and internationally as the Canadian cannabis industry rebounds.